Pancreatic islets contain enzyme activity which catalyzes the phosphorylation by MgATP of cardiac, skeletal, or smooth muscle myosin light chains. The enzyme is activated by calcium (Ka = 10 /iM) and calmodulin (Ka = 2 nM) and inhibited by trifluoperazine (Ki = 10 fiM), a known inhibitor of calmodulin and of insulin secretion. The enzyme binds to a calmodulin affinity column when Ca 2+ is present and is eluted when Ca 2+ is omitted. These are the properties of myosin light chain kinase. Since phosphorylation of smooth muscle myosin is necessary for its activation by actin, the kinase may have a key role in coupling stimuli that increase intracellular calcium to the contractile processes involved in insulin secretion. DIABETES 31:566-570, June 1982.
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nsulin secretion from the pancreatic beta-cell, induced by a number of secretagogues, is accompanied by an increase in intracellular calcium, and secretion may well depend on contractile proteins similar to those of muscle (microfilaments) and cilia (microtubules). Available evidence is consistent with a saltatory movement of insulin granules from the Golgi complex to the plasma membrane of the beta-cell oriented by a lattice of microtubules and powered by actomyosin contraction (reviewed in refs. 1 and 2). Microfilaments may also participate in opening of the plasma membrane during the extrusion of insulin granules. The requirement for extracellular calcium, depolarization of the beta-cell plasma membrane, the requirement for ATP (reviewed in ref. 3) , and potentiation of insulin release by oubain 4 are each reminiscent of muscle contraction. Although calcium is generally believed to be important in coupling stimuli to the insulin secretory process, little spe-cific information exists on how calcium acts in the beta-cell. A prime target for calcium might be myosin light chain kinase (MLCK). This enzyme is inhibited by micromolar concentrations of trifluoperazine, s an inhibitor of calmodulin-requiring enzymes 6 and, indeed, similar low concentrations of trifluoperazine potently inhibit insulin secretion in vitro. 7 -8 MLCK is a recently discovered calcium-dependent enzyme found in smooth, skeletal, and cardiac muscle as well as in nonmuscle tissues such as brain and platelets. 6 Since calmodulin is a regulatory subunit of the enzyme, 9 this accounts for its susceptibility to inhibition by trifluoperazine. The enzyme is an ATP-myosin light chain phosphotransferase. Current evidence suggests that the MgATPase activity of smooth muscle myosin in the phosphorylated state can be activated by actin, whereas the ATPase activity of the unphosphorylated myosin is not affected by actin and remains at a low level. 10 Since MLCK is active only in the presence of Ca 2+ , a Ca 2+ -dependent activation of contraction is achieved. The possibility of pancreatic islets containing MLCK has been mentioned recently in the literature, 1 -2 -11 but attempts to detect the enzyme have not been reported, possibly because standard assay procedures for its activity are more suitable for large amounts of pure enzyme and its substrate (myosin light chains) 12 than for the impure enzyme in small amounts of tissue, such as in pancreatic islets. We have used procedures that enabled us to demonstrate MLCK activity in pancreatic islets.
MATERIALS AND METHODS
Materials. Cardiac (calmodulin-free) and skeletal muscle myosin light chains (not calmodulin-free) were generous gifts of Dr. S. James Stull and Donald Blumenthal 12 and bull testis calmodulin was a generous gift of Dr. Frank Siegel. Smooth muscle myosin light chains were purified from fresh turkey gizzards.
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Tissue preparation. Pancreatic islets were isolated from well-fed Sprague-Dawley rats, washed twice in 200 mM mannitol, 70 mM sucrose, 10 mM triethanolamine chloride, pH 7.5, and 1 mM ethylene-bis (oxyethylene-nitrilo) tetraacetic acid (EGTA) and then washed twice more and ho-mogenized in the same solution without EGTA.
14 Cytosol was the 105,000 x g x 1 h supernatant fraction. MLCK assay. MLCK activity was assayed at 37°C in a volume of 40 fx\ containing 50 mM 3-(N-morpholino)-propanesulfonic acid, pH 7.0, 10 mM magnesium acetate, 15 mM 2-mercaptoethanol, 55 mM mannitol, 18 mM sucrose 25 /nM [y-32 P]ATP (2500 cpm/pmol), and unless stated otherwise, 150 nM calmodulin, 50 /xM cardiac or skeletal muscle myosin phosphorylatable light chains, and 100 /u,M free CaCI 2 . The reaction was started by adding ATP and stopped after 10 min by adding electrophoresis sample buffer to give a final sodium dodecyl sulfate (SDS) concentration of 1%. The samples were immediately heated at 100°C for 2 min and electrophoresis in 0.1% SDS 10% polyacrylamide slab gels was done by the method of Laemmli. 15 32 P incorporation into protein was demonstrated by exposing the gel to X-Omat AR film (E. Kodak Co.) and Cronex Lightning Plus intensifying screens (E. I. DuPont De Nemours Co.) 16 at -70°C for 12-24 h and quantitated by densitometry. The peaks under the densitometric tracings were cut out of the paper on which they were drawn, weighed to estimate their area, and MLCK activity was expressed as a percent of maximum labeling. After the autofluorography the gels were stained for protein with Comassie blue to identify molecular-weight marker proteins. Proteins with the following relative subunit molecular weights were used: rabbit muscle phosphorylase a (92,500), pyruvate kinase (57,000), and aldolase (40,000); cow's milk lactoperoxidase (82,000), bovine serum albumin (68,000), pig heart fumarase (38,000), bovine pancreas chymotrypsinogen (25,000) and RNAse (13,700), and horse heart myoglobin c (17, 200) and cytochrome c (12,500).
Since a crude homogenate was used in the experiment depicted in Figure 1 , NaF (30 mM) and oligomycin (3 /xg/ml) were added to the assay mixture to inhibit ATPases. Skeletal muscle myosin light chains (5 /xM phosphorylatable light chains) were used in experiments depicted in the two upper panels and cardiac muscle myosin light chains (15 /AM of phosphorylatable light chains) were used in the experiments depicted in the lowest panel of Figure 2 . Free calcium concentrations of 5 /xM or lower were maintained by varying the ratio of CaCI 2 to 10 mM EGTA. 17 Higher calcium concentrations were calculated from the measured free calcium in the assay mixture and the added calcium. Free calcium in the assay mixture was measured with antipyrylazo III 18 and in the experiment depicted in the uppermost panel of Figure 2 the free Ca 2+ was 10 /xM before the addition of Ca 2+ . Smooth muscle myosin light chains (8 /ug) were used, when added, in the experiment depicted in Figure 4 . DEAE chromatography. To study calmodulin activation of MLCK, cytosol was chromatographed on diethylaminoethyl-(DEAE)-Sephacel in the presence of EGTA to remove endogenous calmodulin. 19 Cytosol from 1500 islets was dissolved in 1.5 ml of 10 mM sodium phosphate, pH 7.5, 1 mM dithiothreitol, 1 mM EGTA (column buffer), and applied to a 3.7 cm x 0.1 cm 2 DEAE Sephacel column. The column was washed with 0.5 ml of column buffer and then 0.5 ml of column buffer containing 0.15 M KCI. MLCK was eluted with 0.3 M KCI.
Calmodulin-Sepharose chromatography. Calmodulin was coupled to cyanogen bromide-activated Sepharose-4B. 20 Cytosol from 1500 islets was dissolved in 1.0 ml of 75 mM KCI, 1 mM MgCI 2 , 1 mM CaCI 2 , 0.5 mM dithiothreitol and 20 mM Tris chloride, pH 7.5 (column buffer), and applied to a 3.0 x 0.1 cm 2 calmodulin Sepharose column.
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The column was washed with 1.0 ml of column buffer and MLCK was eluted with column buffer containing 1 mM EGTA in place of CaCI 2 . Five fractions of 0.2 ml were collected and 20 /xl of these fractions, the "wash" fraction and the original sample, was used in the MLCK assay. Figure 1 is a photograph of a film exposed to an SDS polyacrylamide gel. It shows that an homogenate of pancreatic islets catalyzes labeling by [y-32 P]ATP of cardiac muscle light chains (mol wt 20,000). Labeling occurred only when both homogenate and light chains were present and it was strongly inhibited by trifluoperazine or by chelating calcium with EGTA. Only the added light chains, in contrast to islet proteins, were labeled. This was accomplished by using a low amount of homogenate equivalent to that from about eight islets. In other experiments, greater than 95% of the myosin light chain kinase activity was found in the islet cytosol; therefore cytosol was used for subsequent studies.
RESULTS
The effects of various calcium, trifluoperazine, and cal- modulin concentrations on the amount of 32 P labeling of the myosin light chain band were estimated by densitometry (Figure 2) . Figure 3 shows the influence of the three effectors on the areas under the peaks from Figure 2 combined with data from additional experiments. The data show that enzyme activity is correlated positively with the calcium and calmodulin concentrations and negatively with the trifluoperazine concentration. One-half maximal enzyme activity was attained at about 10 /xM Ca 2+ in the presence of maximal stimulating calmodulin (150 nM). The average concentration of trifluoperazine that gave 50% inhibition was about 10 /xM. The enzyme was partially purified from islet cytosol by chromatography in the presence of EGTA on DEAE Sephacel to remove calmodulin in order to study activation by exogenous calmodulin. The calmodulin concentration that gave one-half maximal enzyme activity was about 2 nM ( Figure 3 ) and 10 nM calmodulin gave 90% of maximal activity. The low enzyme activity present in the absence of added calmodulin might be due to a trace of calmodulin present in the enzyme preparation.
The islet MLCK activity binds to a calmodulin affinity column ( Figure 4 ) and this strongly indicates that the enzyme is 
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a calmodulin-requiring enzyme. When Ca 2+ was present in the column buffer during the application of the islet cytosol sample and during washing of the column, the column eluate contained negligible MLCK activity, but when Ca 2+ was omitted from, and EGTA added to, the column buffer (fractions 1-5) MLCK activity was eluted from the column. (MLCK activity was concentrated in fractions 3 and 4.) Smooth muscle myosin light chains were used as the substrate for MLCK in this experiment. When the light chains were omitted from the assay mixture, none of the column fractions catalyzed labeling of a 20,000-mol-wt band.
A phosphoprotein with a subunit mol wt of 54,000, and apparently a protein kinase besides MLCK, was eluted from the calmodulin column. These proteins are the subjects of a separate investigation.
DISCUSSION
Cells normally maintain free calcium in the cytoplasm at a concentration of about 10~7 M. An increase of intracellularfree calcium to above 10 /xM is believed to activate many calcium-dependent processes, such as muscle contraction or insulin secretion. The present work shows that the concentration of Ca 2+ , which gives one-half maximal activation of pancreatic islet MLCK, is approximately 10 ^.M (Figures 2  and 3 ). The concentrations of Ca 2+ and calmodulin that activate the islet MLCK are very similar to those that activate the purified enzyme from skeletal muscle 12 and the concentrations of trifluoperazine that inhibit the islet MLCK (Figures 2  and 3 ) are similar to those that inhibit insulin secretion by isolated pancreatic islets (10-20 /u-M).
Maximal inhibition of MLCK of 60% by 20 i*M trifluoperazine was observed (Figure 3 ). It is interesting that higher concentrations of trifluoperazine were either no more inhibitory or less inhibitory (data not shown). This apparent dual effect of trifluoperazine matches the effects of calmodulin inhibitors on insulin release and on activities of other secretory tissues. We have noticed that 100 /xM trifluoperazine is sometimes less or no more inhibitory of insulin release from isolated pancreatic islets than is 10 /xM trifluoperazine. Others have noticed that 50 fxM trifluoperazine 7 or 200 /u,M W-7 (also a calmodulin inhibitor at 25 /u.M) 21 increased basal insulin release from pancreatic islets. In experiments on human neutrophils, Smolen et al. 22 found that 30 /*M trifluoperazine inhibited lysosomal enzyme release essentially 100%, whereas 100/u.M trifluoperazine inhibited enzyme release only 0-17%. Similarly, Egrie (working in F. Siegel's laboratory) 23 found that 100 /AM desipramine inhibited calmodulin-dependent activation of adrenal medullary cyclic nucleotide phosphodiesterase 83%, but 1-10 mM desipramine was less inhibitory. It is possible that at high concentrations the calmodulin "inhibitors" may act like calmodulin itself and be stimulatory.
The effect of insulin secretagogues on calcium handling by the beta-cell is believed to be of fundamental importance in stimulus-secretion coupling. 3 Besides the fact that the beta-cell contains microfilamentous proteins, such as actin and myosin, and that calcium is often involved in contractile processes, there seems to be little direct biochemical evidence for the interaction of calcium with microfilaments in the beta-cell. The work reported here strongly points toward MLCK being a potential target for calcium in the beta-cell. When the binding sites of calmodulin are saturated with cal- cium, myosin light chain kinase should catalyze the phosphorylation of myosin which, in turn, should permit myosin to interact with actin so that contraction can occur. Trifluoperazine, by preventing the activation of the myosin kinase by calmodulin, should inhibit insulin release ( Figure 5 ).
